Key facts
- Notable investors include Enterprise Ireland, Royal College of Surgeons Ireland.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Phyxiom
- ·The full record, as it builds
Funding rounds
No funding rounds for Phyxiom are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Phyxiom
Developer of an AI platform designed to transform the clinical outcomes for patients with uncontrolled asthma and COPD. The company's platform incorporates a remote diagnostics platform, which is device-independent, integrating smart inhalers and spirometry devices into patient data for time-based analysis and acts as an intelligent decision support system for physicians delivering patient clinical data in an easily accessible form.
- Sector
- Healthcare
- HQ
- Dublin, Ireland
- Founded
- 2021
- Employees
- 3
- Website
- phyxiom.com/
- Ownership
- Privately Held (backing)
Phyxiom doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Phyxiom shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Phyxiom in its N-PORT filings yet. We sweep new filings monthly.